ATE297758T1 - Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie - Google Patents

Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie

Info

Publication number
ATE297758T1
ATE297758T1 AT01917183T AT01917183T ATE297758T1 AT E297758 T1 ATE297758 T1 AT E297758T1 AT 01917183 T AT01917183 T AT 01917183T AT 01917183 T AT01917183 T AT 01917183T AT E297758 T1 ATE297758 T1 AT E297758T1
Authority
AT
Austria
Prior art keywords
pneumococces
diphteria
vaccine against
polysaccharide conjugates
against tetanus
Prior art date
Application number
AT01917183T
Other languages
English (en)
Inventor
Dominique Schulz
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8848189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297758(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Application granted granted Critical
Publication of ATE297758T1 publication Critical patent/ATE297758T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01917183T 2000-03-17 2001-03-19 Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie ATE297758T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003407A FR2806304B1 (fr) 2000-03-17 2000-03-17 Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
PCT/FR2001/000820 WO2001068128A1 (fr) 2000-03-17 2001-03-19 Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie

Publications (1)

Publication Number Publication Date
ATE297758T1 true ATE297758T1 (de) 2005-07-15

Family

ID=8848189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917183T ATE297758T1 (de) 2000-03-17 2001-03-19 Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie

Country Status (11)

Country Link
US (1) US20030099672A1 (de)
EP (1) EP1267922B1 (de)
AT (1) ATE297758T1 (de)
AU (1) AU2001244275A1 (de)
CA (1) CA2402807A1 (de)
DE (1) DE60111507T2 (de)
DK (1) DK1267922T3 (de)
ES (1) ES2240432T3 (de)
FR (1) FR2806304B1 (de)
PT (1) PT1267922E (de)
WO (1) WO2001068128A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK288007B6 (sk) * 2000-06-29 2012-10-02 Glaxosmithkline Biologicals S. A. Multivalent vaccine composition, process for its producing, and its use
AR056396A1 (es) 2005-06-27 2007-10-10 Glaxosmithkline Biolog Sa Composicion inmunogenica
TR201900418T4 (tr) 2005-12-22 2019-02-21 Glaxosmithkline Biologicals Sa Pnömokok polisakkarit konjugat aşısı.
GB0607088D0 (en) * 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
EA020817B1 (ru) 2007-06-26 2015-02-27 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
KR102057217B1 (ko) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20121597A1 (it) * 2012-09-25 2014-03-26 Beta Pharma S A Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN105007935A (zh) * 2012-12-18 2015-10-28 葛兰素史密丝克莱恩生物有限公司 用于保护免于白喉和/或破伤风的缀合物
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
IL264553B2 (en) * 2016-08-05 2023-04-01 Sanofi Pasteur Inc A multivalent pneumococcal protein-polysaccharide conjugate preparation
CN109862908B (zh) * 2016-08-05 2023-05-02 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN118356485A (zh) 2017-06-10 2024-07-19 创赏公司 提供改善的免疫原性和亲合力的具有二价或多价缀合物多糖的多价缀合物疫苗
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
CN111757754B (zh) 2018-02-05 2024-07-05 赛诺菲巴斯德有限公司 多价肺炎球菌多糖-蛋白质缀合物组合物
IL276230B2 (en) * 2018-02-05 2024-01-01 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR20190121713A (ko) 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
EP4003410A1 (de) * 2019-07-31 2022-06-01 Sanofi Pasteur, Inc. Multivalente pneumokokken-polysaccharid-protein-konjugat-zusammensetzungen und verfahren zu ihrer verwendung
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CN113607939B (zh) * 2021-08-05 2024-10-22 艾美探索者生命科学研发有限公司 肺炎球菌多糖结合疫苗各型结合原液吸附率测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
FR2682388B1 (fr) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
DK1090642T3 (da) * 1995-06-07 2008-09-22 Glaxosmithkline Biolog Sa Vacciner omfattende et polysaccharidantigen-bæreprotein-konjugat og frit bæreprotein
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
JP2002502830A (ja) * 1998-02-05 2002-01-29 ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン タンパク質−多糖コンジュゲートおよびワクチンの製造中に遊離タンパク質を除去するための、接近が制限された媒介材料を用いる簡素化された方法

Also Published As

Publication number Publication date
WO2001068128A1 (fr) 2001-09-20
EP1267922B1 (de) 2005-06-15
EP1267922A1 (de) 2003-01-02
FR2806304B1 (fr) 2002-05-10
US20030099672A1 (en) 2003-05-29
DE60111507D1 (de) 2005-07-21
PT1267922E (pt) 2005-09-30
DK1267922T3 (da) 2005-10-17
FR2806304A1 (fr) 2001-09-21
ES2240432T3 (es) 2005-10-16
DE60111507T2 (de) 2006-05-11
CA2402807A1 (en) 2001-09-20
AU2001244275A1 (en) 2001-09-24

Similar Documents

Publication Publication Date Title
ATE297758T1 (de) Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie
EA200901578A1 (ru) Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
BRPI0009163B8 (pt) composição imunogênica e vacina que a compreende
TR201900418T4 (tr) Pnömokok polisakkarit konjugat aşısı.
UY26801A1 (es) Composición de vacuna
CY1110140T1 (el) Εμβολιασμος με μηνιγγοκοκκικο συζευγμα
NZ598367A (en) Multiple vaccination including serogroup C meningococcus
NZ602682A (en) Multivalent meningococcal polysaccharide-protein conjugate vaccine
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
CY1111814T1 (el) Ενσωματωση του εμβολιασμου μηνιγγιτιδοκοκκικων συζευματων
CO5241278A1 (es) Vacuna
UA99703C2 (en) Use of streptococcus pneumoniae immunogenic composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267922

Country of ref document: EP